An interdisciplinary multi-center research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the ...
CRB-701 targets Nectin-4, delivering chemotherapy directly to cancer cells, minimizing damage to healthy tissue. The FDA's fast track designation aims to expedite CRB-701's development for HNSCC and ...